Evidence map›Paper›PMID 27807161›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2016

Bottom-Up versus Top-Down Induction of Sleep by Zolpidem Acting on Histaminergic and Neocortex Neurons.

David S Uygun, Zhiwen Ye, Anna Y Zecharia, Edward C Harding, Xiao Yu, Raquel Yustos, Alexei L Vyssotski, Stephen G Brickley, Nicholas P Franks, William Wisden

Open access · hybridAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Sleep disorders and sleep medications as risk factors for dementia in kidney transplant recipients: A retrospective cohort study.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Article
  5. Article
  6. Comparative analysis of adenosine 1 receptor expression and function in hippocampal and hypothalamic neurons.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Knockdown of GABANature communications · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

David S UygunDepartment of Life Sciences and.ORCID 0000-0002-6592-3223
Zhiwen YeDepartment of Life Sciences and.ORCID 0000-0003-4311-1037
Anna Y ZechariaDepartment of Life Sciences and.
Edward C HardingDepartment of Life Sciences and.ORCID 0000-0002-5803-2780
Xiao YuDepartment of Life Sciences and.ORCID 0000-0001-9441-1705
Raquel YustosDepartment of Life Sciences and.ORCID 0000-0001-9387-242X
Alexei L VyssotskiInstitute of Neuroinformatics, University of Zurich and ETH Zurich, Zurich 8057, Switzerland.
Stephen G BrickleyDepartment of Life Sciences and.ORCID 0000-0002-0930-7346
Nicholas P FranksDepartment of Life Sciences and w.wisden@imperial.ac.uk n.franks@imperial.ac.uk.ORCID 0000-0003-4874-4212
William WisdenDepartment of Life Sciences and w.wisden@imperial.ac.uk n.franks@imperial.ac.uk.ORCID 0000-0003-4743-0334
London Centre for Nanotechnology · GBSIB Swiss Institute of Bioinformatics · CH

Funding

Biotechnology and Biological Sciences Research Council BB/F017324/1Biotechnology and Biological Sciences Research Council BB/K018159/1Medical Research Council G0800399Medical Research Council G0901892Wellcome TrustWellcome Trust 107839/Z/15/ZWellcome Trust WT094211MA
6 · The paper itself

Abstract

Zolpidem, a GABA SIGNIFICANCE STATEMENT: Many people who find it hard to get to sleep take sedatives. Zolpidem (Ambien) is the most widely prescribed "sleeping pill." It makes the inhibitory neurotransmitter GABA work better at its receptors throughout the brain. The sleep induced by zolpidem does not resemble natural sleep because it produces a lower power in the brain waves that occur while we are sleeping. We show using mouse genetics that zolpidem only needs to work on specific parts and cell types of the brain, including histamine neurons in the hypothalamus, to induce sleep but without reducing the power of the sleep. This knowledge could help in the design of sleeping pills that induce a more natural sleep.

Indexed as

AnimalsDose-Response Relationship, DrugFemaleHistamine AgentsHypnotics and SedativesMaleMiceMice, Inbred C57BLNeocortexNeuronsPyridinesReceptors, GABA-ASleepSleep Aids, PharmaceuticalZolpidemHistamine AgentsHypnotics and SedativesPyridinesReceptors, GABA-ASleep Aids, PharmaceuticalZolpidemGABA-A receptorhistamineinsomniasleeptuberomammillary nucleuszolpidem

Identifiers

PMID27807161
PMCPMC5148237
OpenAlexW2548374292

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.